Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Homology Medicines Inc (FIXX)
NASDAQ:FIXX
RESEARCH TOOLSreports
Holding FIXX?
Track your performance easily
See the Price Targets and Ratings of:
FIXX Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FIXX Stock 12 Month Forecast
There Are No Analyst Ratings for FIXX In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
FIXX Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Robert W. Baird
$1.5
Hold
60.48%
Upside
Reiterated
11/16/23
Analysts' Opinions Are Mixed on These Healthcare Stocks: Homology Medicines (NASDAQ: FIXX), Align Tech (NASDAQ: ALGN) and Calidi Biotherapeutics (NYSE MKT: CLDI)
Credit Suisse
$1.7
Hold
81.88%
Upside
Reiterated
08/15/23
Homology Medicines (FIXX) PT Lowered to $1.70 at Credit SuisseCredit Suisse analyst Richard Law lowered the price target on Homology Medicines (NASDAQ: FIXX) to $1.70 (from $2.00) while maintaining a Neutral rating.
H.C. Wainwright
$20
Buy
2039.72%
Upside
Reiterated
05/15/23
H.C. Wainwright Sticks to Their Buy Rating for Homology Medicines (FIXX)
Chardan Capital
$7
Buy
648.90%
Upside
Reiterated
05/11/23
Homology Medicines price target lowered to $7 from $8 at ChardanHomology Medicines price target lowered to $7 from $8 at Chardan
RBC Capital
$3
Hold
220.96%
Upside
Reiterated
05/11/23
Homology Medicines (FIXX) Gets a Hold from RBC Capital
Canaccord Genuity
$7
Buy
648.90%
Upside
Reiterated
04/06/23
Homology Medicines price target lowered to $7 from $19 at CanaccordHomology Medicines price target lowered to $7 from $19 at Canaccord
BTIG
$12
Buy
1183.83%
Upside
Reiterated
04/03/23
BTIG Sticks to Its Buy Rating for Homology Medicines (FIXX)
Best Analysts Covering Homology Medicines
Which Analyst Should I Follow If I Want to Buy FIXX and Sell After:
1 Month
xxx
Success Rate
6/14 ratings generated profit
Average Return
-3.22%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 42.86% of your transactions generating a profit, with an average return of -3.22% per trade.
3 Months
xxx
Success Rate
2/9 ratings generated profit
Average Return
-12.86%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 22.22% of your transactions generating a profit, with an average return of -12.86% per trade.
1 Year
Success Rate
0/9 ratings generated profit
Average Return
-40.42%
reiterated a buy rating 2 years ago
Copying Michelle Gilson's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -40.42% per trade.
2 Years
xxx
Success Rate
0/14 ratings generated profit
Average Return
-61.74%
reiterated a xxx
rating 2 years ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -61.74% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
FIXX Analyst Recommendation Trends
Rating
May 23
Jun 23
Jul 23
Aug 23
Nov 23
Strong Buy
0
0
0
0
0
Buy
9
6
4
1
0
Hold
5
2
4
3
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
8
8
4
5
Each month's total comprises the sum of three months' worth of ratings.
FIXX Stock Forecast FAQ
What is FIXX’s average 12-month price target, according to analysts?
Currently, no data Available
What is FIXX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for FIXX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is FIXX a Buy, Sell or Hold?
Currently, no data Available
What is Homology Medicines Inc’s price target?
Currently, no data Available
What do analysts say about Homology Medicines Inc?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of FIXX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.